TrinityPoint Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $450K | Buy |
7,948
+1,398
| +21% | +$79.1K | 0.06% | 235 |
|
|
2024
Q3 | $339K | Buy |
6,550
+522
| +9% | +$27K | 0.05% | 252 |
|
|
2024
Q2 | $250K | Sell |
6,028
-743
| -11% | -$30.9K | 0.04% | 275 |
|
|
2024
Q1 | $367K | Sell |
6,771
-1,357
| -17% | -$73.6K | 0.06% | 225 |
|
|
2023
Q4 | $417K | Sell |
8,128
-29,722
| -79% | -$1.53M | 0.08% | 209 |
|
|
2023
Q3 | $2.2M | Buy |
37,850
+1,113
| +3% | +$64.6K | 0.44% | 61 |
|
|
2023
Q2 | $2.35M | Buy |
36,737
+28,210
| +331% | +$1.8M | 0.46% | 62 |
|
|
2023
Q1 | $591K | Buy |
8,527
+578
| +7% | +$40.1K | 0.13% | 158 |
|
|
2022
Q4 | $572K | Buy |
7,949
+631
| +9% | +$45.4K | 0.13% | 153 |
|
|
2022
Q3 | $520K | Buy |
7,318
+1,729
| +31% | +$123K | 0.12% | 154 |
|
|
2022
Q2 | $430K | Buy |
5,589
+714
| +15% | +$54.9K | 0.1% | 176 |
|
|
2022
Q1 | $356K | Buy |
4,875
+1,494
| +44% | +$109K | 0.06% | 220 |
|
|
2021
Q4 | $211K | Buy |
+3,381
| New | +$211K | 0.04% | 293 |
|
|
2020
Q1 | – | Sell |
-3,154
| Closed | -$202K | – | 195 |
|
|
2019
Q4 | $202K | Buy |
+3,154
| New | +$202K | 0.07% | 205 |
|
|
2019
Q2 | – | Sell |
-31,652
| Closed | -$1.51M | – | 173 |
|
|
2019
Q1 | $1.51M | Buy |
31,652
+5,845
| +23% | +$279K | 0.74% | 35 |
|
|
2018
Q4 | $1.34M | Buy |
+25,807
| New | +$1.34M | 0.82% | 29 |
|